In the multivariate analysis on patients with invasive EMPD, the overexpression of both CDK4/cyclin D1 was not associated with poor survival outcomes (HR: 3.14, p = 0.14), possibly due to the insufficient number of patients with invasive EMPD. The gene discussed is CDK4; the disease is extramammary Paget disease.